The peptide and anticoagulant drugs market encompasses a wide range of therapeutic products designed to prevent blood clotting and regulate hemostasis. These drugs are essential in treating conditions such as deep vein thrombosis, pulmonary embolism, atrial fibrillation, and other cardiovascular diseases. Peptide-based drugs offer a targeted approach by interacting with specific receptors, while anticoagulants help manage and prevent clot formation.